These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The non-antithrombotic therapeutic potential of heparin and related heparinoids in cardiovascular diseases. Hasdai D; Blumberg N; Battler A Coron Artery Dis; 1994 Jan; 5(1):81-91. PubMed ID: 8136936 [No Abstract] [Full Text] [Related]
4. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease? Kleschyov AL; Sen' VD Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686 [No Abstract] [Full Text] [Related]
5. [Heparin: its mechanism of action and use in cardiology]. Serneri GG; Rostagno C G Ital Cardiol; 1990 Jul; 20(7):670-4. PubMed ID: 2245907 [No Abstract] [Full Text] [Related]
6. [Use of magnesium heparinate in cardiovascular therapeutics]. Renner C; Cauwel G Sem Hop Ther; 1974; 50(5-6):373-6. PubMed ID: 4612714 [No Abstract] [Full Text] [Related]
7. [Long-term use of heparin in cardiovascular diseases. Proposal for a new administration method: aerosols]. Molino N; Belluardo C Minerva Cardioangiol; 1973; 21(7):553-7. PubMed ID: 4756349 [No Abstract] [Full Text] [Related]
8. Pharmacology of the low-molecular-weight heparins. Fareed J; Hoppensteadt DA Semin Thromb Hemost; 1996; 22 Suppl 2():13-8. PubMed ID: 8946614 [No Abstract] [Full Text] [Related]
10. [Anticoagulant therapy in cardiovascular diseases. I. Thrombus formation and anticoagulants]. Latallo ZS; Malanowicz W Kardiol Pol; 1970; 13(4):351-8. PubMed ID: 4099312 [No Abstract] [Full Text] [Related]
11. [Sodium iodoheparinate; its value in the treatment of cardiovascular diseases]. Warembourg H; Delomez M Lille Med; 1967 Feb; 12(2):Suppl:129-33. PubMed ID: 5623383 [No Abstract] [Full Text] [Related]
12. [Update on anticoagulant therapy]. Gensini GF; Falciani M; Dilaghi B; Poli D Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):673-80. PubMed ID: 12497803 [No Abstract] [Full Text] [Related]
13. [Guiding principles for anticoagulant therapy in cardiology]. Lengyel M Orv Hetil; 2010 Jun; 151(23):950-3. PubMed ID: 20494891 [No Abstract] [Full Text] [Related]
14. Clinical experience with parenteral heparin-lipotropic therapy in cardiovascular disease; a preliminary report. READ JT; OBETZ RC Ohio State Med J; 1955 Mar; 51(3):221-5. PubMed ID: 14356684 [No Abstract] [Full Text] [Related]
15. The management of adequate anticoagulant therapy and its complications. Royston GR Vasc Dis; 1966 Oct; 3(5):295-304. PubMed ID: 4162445 [No Abstract] [Full Text] [Related]